@article{Dubey_A-2022_88239,
title = {Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections},
author = {Dubey, A. and Chaudhry, S. and Singh, H. and Gupta, V. and Kaushik, A.},
month = {mar},
year = {2022},
abstract = {Optimized therapeutic bio-compounds supported by bio-acceptable nanosystems (i.e., precise nanomedicine) have ability to promote health via maintaining body structure, organ function, and controlling chronic and acute effects. Therefore, nano-nutraceuticals (designed to neutralize virus, inhibit virus bindings with receptors, and support immunity) utilization can manage COVID-19 pre/post-infection effects. To explore these approaches well, our mini-review explores optimized bio-active compounds, their ability to influence SARS-CoV-2 infection, improvement in performance supported by precise nanomedicine approach, and challenges along with prospects. Such optimized pharmacologically relevant therapeutic cargo not only affect SARS-CoV-2 but will support other organs which show functional alternation due to SARS-CoV-2 for example, neurological functions. Hence, coupling the nutraceuticals with the nano-pharmacology perspective of higher efficacy via targeted delivery action can pave a novel way for health experts to plan future research needed to manage post COVID-19 infection effect where a longer efficacy with no side-effects is a key requirement.},
volume = {33},
journal = {Biotechnology Reports},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.btre.2022.e00712},
}
